Novel Live Attenuated Type 3 Poliomyelitis Vaccines (PATH)

N/A

Report date: 2022/12/24 20:00:29

Base Information

Drug NameNovel Live Attenuated Type 3 Poliomyelitis Vaccines (PATH)
Drug Alias NameNovel Live Attenuated Type 3 Oral Poliomyelitis VaccinesNovel Oral Polio Vaccine Type 3 (nOPV3)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPanamaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPath
China Registration ClassN/A

Develop Information

Active CompaniesPath
Inactive CompaniesN/A
Active IndicationsPoliomyelitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A